Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients
Authors:
Abstract
Background: Venom immunotherapy (VIT) is regarded as an established and efficient treatment of Hymenoptera venom allergy. Different frequencies of side‐effects have been reported in the literature, depending on the hyposensitization regimen (conventional outpatient programme, rush immunotherapy, ultra rush immunotherapy) and the venom preparation. Aim of this study was to evaluate safety and tolerance of rush VIT in patients treated with a 7‐day protocol in our department.Methods: VIT protocols of 178 patients treated at the Department of Dermatology and Allergy of the University of Bonn were analysed retrospectively. All patients had been treated with a standardized venom preparations (ALK‐SQTM). We used a modified VIT‐protocol with a 2‐day break to reduce systemic side‐effects.Results: During the course of VIT in 15 patients (8.4%) systemic reactions grade I (Mueller scale) were observed, in seven (3.9%) grade II, in six (3.4%) grade III and in four (2.2%) grade IV. A total of 146 patients (82.1%) had no or only local reactions.Conclusions: The rate of systemic adverse reactions Mueller Grade I–IV of 17.9% of the ‘Bonn rush VIT protocol’ appears to be relatively low compared with the data in the literature.Keywords
This publication has 12 references indexed in Scilit:
- Side‐effects of insect venom immunotherapy:results from an EAACI multicenter studyAllergy, 2000
- Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injectionsJournal of Allergy and Clinical Immunology, 2000
- Allergy to bumblebee venom. III. Immunotherapy follow‐up study (safety and efficacy) in patients with occupational bumblebee‐venom anaphylaxisAllergy, 1999
- Standardisierte Schnellhyposensibilisierung mit einem gereinigten Hymenopterengift bei WespengiftallergieDie Dermatologie, 1997
- Safety of Hymenoptera venom rush immunotherapyAllergy, 1997
- The incidence and nature of adverse reactions to injection immunotherapy in bee and wasp venom allergyClinical & Experimental Allergy, 1995
- Rapid Hymenoptera venom immunotherapy: comparative safety of three protocolsClinical & Experimental Allergy, 1993
- Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safetyJournal of Allergy and Clinical Immunology, 1992
- Immunotherapy with Hymenoptera venomsAllergy, 1987
- Schnellhyposensibilisierung mit Hymenopterengiften: Verträglichkeit und TherapieerfolgDMW - Deutsche Medizinische Wochenschrift, 1987